Crispino, in remission from prostate cancer diagnosed when he was just 44, is so respected in the medical community that he was part of the panel that developed guidelines for treatment of localized prostate cancer — they were recently adopted by the American Urological Association, American Society for Radiation Oncology and the Society of Urologic.. read more →

UK-based scientists have developed a new three-in-one blood test able to identify the patients with advanced prostate cancer most likely to benefit from PARP inhibitors, with the potential to ‘transform’ treatment of the disease. Read more read more →

Researchers at Moffitt Cancer Center have revealed the mechanism that explains the transformation process of prostate cells into castration-resistant cancer cells. They’ve also identified a new drug candidate that targets this specific mechanism, preventing the growth and proliferation of these aggressive and deadly cancer cells. Read more read more →

The Fifth Annual Prostate Health Education Symposium is being presented by the Prostate Health Education Network, a nonprofit advocacy and education group founded, in 2003, by Boston area businessman Thomas A. Farrington. Read more read more →

I recently had an awkward conversation with my doctor. I was getting a routine physical, and he recommended that I get a PSA test for prostate cancer. I’m 63. Read more read more →